Press Releases from DelveInsight Business Research LLP (4751 total)
IgA Nephropathy Pipeline Appears Promising With 25+ Leading Biotech and Pharma C …
DelveInsight's, "IgA Nephropathy Pipeline Insight, 2025," report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in IgA Nephropathy pipeline landscape. It covers the…
Human papillomavirus (HPV) Associated Cancer Pipeline Insights 2025: Key 50+ Com …
DelveInsight's, "Human papillomavirus (HPV) Associated Cancer Pipeline Insight, 2025," report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Human papillomavirus (HPV) Associated…
Down Syndrome Clinical, Companies, Therapeutic Assessment, Therapies, Treatment …
Down Syndrome Pipeline constitutes 5+ key companies continuously working towards developing 5+ Down Syndrome treatment therapies, analyzes DelveInsight.
Down Syndrome Overview:
Down Syndrome (DS) is a genetic…
Diabetes Clinical, Companies, Therapeutic Assessment, Therapies, Treatment Algor …
Diabetes Pipeline constitutes 200+ key companies continuously working towards developing 200+ Diabetes treatment therapies, analyzes DelveInsight.
Diabetes Overview:
Diabetes is a long-term metabolic condition marked by elevated…
DelveInsight Unveils Insightful "US Healthcare Outlook Report" Highlighting Mark …
DelveInsight, a leading global healthcare market research and consulting firm, today published its comprehensive "US Healthcare Outlook Report." This landmark analysis delivers a forward-looking view…
Anti-CD38 antibody Clinical, Companies, Therapeutic Assessment, Therapies, Treat …
Anti-CD38 antibody Pipeline constitutes 10+ key companies continuously working towards developing 12+ Anti-CD38 antibody treatment therapies, analyzes DelveInsight.
Anti-CD38 antibody Overview:
CD38 is a membrane-bound protein initially…
PD-1 and PD-L1 Inhibitors Clinical, Companies, Therapeutic Assessment, Therapies …
PD-1 and PD-L1 Inhibitors Pipeline constitutes 180+ key companies continuously working towards developing 200+ PD-1 and PD-L1 Inhibitors treatment therapies, analyzes DelveInsight.
PD-1 and PD-L1 Inhibitors…
Bevacizumab Clinical, Companies, Therapeutic Assessment, Therapies, Treatment Al …
Bevacizumab Pipeline constitutes 25+ key companies continuously working towards developing 30+ Bevacizumab treatment therapies, analyzes DelveInsight.
Bevacizumab Overview:
Bevacizumab, marketed as Avastin, is a therapeutic agent approved…
Adeno-Associated Virus (AAV) Vectors in Gene Therapy Clinical, Companies, Therap …
Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline constitutes 180+ key companies continuously working towards developing 250+ Adeno-Associated Virus (AAV) Vectors in Gene Therapy treatment…
Blastic Plasmacytoid Dendritic Cell Neoplasm Clinical, Companies, Therapeutic As …
Blastic Plasmacytoid Dendritic Cell Neoplasm Pipeline constitutes 2+ key companies continuously working towards developing 2+ Blastic Plasmacytoid Dendritic Cell Neoplasm treatment therapies, analyzes DelveInsight.
Blastic Plasmacytoid…
Traumatic Brain Injury Clinical, Companies, Therapeutic Assessment, Therapies, T …
Traumatic Brain Injury Pipeline constitutes 20+ key companies continuously working towards developing 22+ Traumatic Brain Injury treatment therapies, analyzes DelveInsight.
Traumatic Brain Injury Overview:
Traumatic brain injury…
Spinocerebellar Ataxias Clinical, Companies, Therapeutic Assessment, Therapies, …
Spinocerebellar Ataxias Pipeline constitutes 8+ key companies continuously working towards developing 10+ Spinocerebellar Ataxias treatment therapies, analyzes DelveInsight.
Spinocerebellar Ataxias Overview:
Spinocerebellar ataxia (SCA) is a rare,…
Postherpetic Neuralgia Clinical, Companies, Therapeutic Assessment, Therapies, T …
Postherpetic Neuralgia Pipeline constitutes 3+ key companies continuously working towards developing 3+ Postherpetic Neuralgia treatment therapies, analyzes DelveInsight.
Postherpetic Neuralgia Overview:
Postherpetic neuralgia (PHN) is a frequent…
Non Muscle Invasive Bladder Cancer Clinical, Companies, Therapeutic Assessment, …
Non Muscle Invasive Bladder Cancer Pipeline constitutes 20+ key companies continuously working towards developing 25+ Non Muscle Invasive Bladder Cancer treatment therapies, analyzes DelveInsight.
Non Muscle…
Hypoglycemia Clinical, Companies, Therapeutic Assessment, Therapies, Treatment A …
Hypoglycemia Pipeline constitutes 10+ key companies continuously working towards developing 12+ Hypoglycemia treatment therapies, analyzes DelveInsight.
Hypoglycemia Overview:
Hypoglycemia is typically defined as a plasma glucose level…
Hyperuricemia Clinical, Companies, Therapeutic Assessment, Therapies, Treatment …
Hyperuricemia Pipeline constitutes 10+ key companies continuously working towards developing 12+ Hyperuricemia treatment therapies, analyzes DelveInsight.
Hyperuricemia Overview:
Hyperuricemia refers to elevated levels of uric acid in…
Huntington's Disease Clinical, Companies, Therapeutic Assessment, Therapies, Tre …
Huntington's Disease Pipeline constitutes 20+ key companies continuously working towards developing 20+ Huntington's Disease treatment therapies, analyzes DelveInsight.
Huntington's Disease Overview:
Huntington's disease is a hereditary, progressive…
Spasticity Pipeline Appears Promising With 10+ Leading Biotech and Pharma Compan …
DelveInsight's, "Spasticity Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Spasticity pipeline landscape. It covers the Spasticity pipeline…
Lewy Body Disease Pipeline Appears Promising With 10+ Leading Biotech and Pharma …
DelveInsight's, "Lewy Body Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Lewy Body Disease pipeline landscape. It…
Homocystinuria Pipeline Appears Promising With 3+ Leading Biotech and Pharma Com …
DelveInsight's, "Homocystinuria Pipeline Insight, 2025" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Homocystinuria pipeline landscape. It covers the pipeline drug…
Retinal Detachment Market Set for Steady Expansion by 2032, Driven by Innovation …
The retinal detachment market is projected to expand at a compound annual growth rate (CAGR) of 6.87% between 2025 and 2032. This anticipated growth is…
Dermal Fillers Market Set for Steady Expansion by 2032, Driven by Innovation and …
The dermal fillers market was valued at USD 6,238.22 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of…
Thrombectomy Devices Market Set for Steady Expansion by 2032, Driven by Innovati …
The thrombectomy devices market was valued at USD 1,656.88 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of…
Vascular Grafts Market Set for Steady Expansion by 2032, Driven by Innovation an …
The global vascular grafts market was valued at USD 1,863.09 million in 2024 and is projected to grow at a CAGR of 6.86% during the…
Vascular Stents Market Set for Steady Expansion by 2032, Driven by Innovation an …
The global vascular stents market was valued at USD 11,232.93 million in 2024 and is projected to grow at a CAGR of 6.35% from 2025…
Spinal Implants Market Set for Steady Expansion by 2032, Driven by Innovation an …
The Spinal Implants market is growing steadily, driven by the rise in endovascular procedures, preference for minimally invasive interventions, and demand for quicker recovery. Advancements…
Tumor Ablation Market Set for Steady Expansion by 2032, Driven by Innovation and …
The global tumor ablation market was valued at USD 1,703.26 million in 2024 and is projected to grow at a CAGR of 13.30% from 2025…
High Flow Oxygen Therapy Devices Market Set for Steady Expansion by 2032, Driven …
The global high-flow oxygen therapy (HFOT) devices market is projected to grow at a CAGR of 2.31% between 2025 and 2032. This growth is primarily…
Seasonal Allergic Rhinitis Therapeutics Market Size Report 2032: Emerging Therap …
DelveInsight's report titled "Seasonal Allergic Rhinitis Market Insights, Epidemiology, and Market Forecast 2032" comprehensively analyzes Seasonal Allergic Rhinitis. The report includes a detailed examination of…
Asthma Therapeutics Market Size Report 2034: Emerging Therapies and Future Growt …
DelveInsight's "Asthma Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of asthma, historical and forecasted epidemiology, as well as the…
Bronchitis Therapeutics Market Size Report 2032: Emerging Therapies and Future G …
DelveInsight's "Bronchitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Bronchitis, historical and forecasted epidemiology as well as the Bronchitis…
Diffuse cutaneous systemic sclerosis Treatment Market Size Report 2032: Emerging …
DelveInsight's "Diffuse Cutaneous Systemic Sclerosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Diffuse Cutaneous Systemic Sclerosis, historical and forecasted…
Cholestatic Pruritus Treatment Market Size Report 2032: Emerging Therapies and F …
DelveInsight's "Cholestatic Pruritus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Cholestatic Pruritus, historical and forecasted epidemiology as well as…
Dyschromia Treatment Market Size Report 2032: Emerging Therapies and Future Grow …
DelveInsight's "Dyschromia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Dyschromia, historical and forecasted epidemiology as well as the Dyschromia…
Lamellar Ichthyosis Treatment Market Size Report 2032: Emerging Therapies and Fu …
DelveInsight's "Lamellar Ichthyosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Lamellar Ichthyosis, historical and forecasted epidemiology as well as…
Mastocytosis Treatment Market Size Report 2032: Emerging Therapies and Future Gr …
DelveInsight's "Mastocytosis Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Mastocytosis, historical and forecasted epidemiology as well as…
Hidradenitis Treatment Market Size Report 2032: Emerging Therapies and Future Gr …
DelveInsight's "Hidradenitis Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hidradenitis, historical and forecasted epidemiology as well as…
Acral lentiginous melanoma Treatment Market Size Report 2032: Emerging Therapies …
DelveInsight's "Acral lentiginous melanoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Acral lentiginous melanoma, historical and forecasted epidemiology as…
Skin Neoplasms Treatment Market Size Report 2032: Emerging Therapies and Future …
DelveInsight's "Skin Neoplasms Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Skin Neoplasms, historical and forecasted epidemiology as…
Cutaneous Squamous cell Carcinom Treatment Market Size Report 2034: Emerging The …
DelveInsight's "Cutaneous Squamous Cell Carcinoma Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Cutaneous Squamous Cell Carcinoma (CSCC), historical…
Basal Cell Carcinoma (Basal Cell Epithelioma) Treatment Market Size Report 2034: …
DelveInsight's "Basal Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of Basal Cell Carcinoma, historical and forecasted epidemiology as well…
Cutaneous Lupus Erythematosus Treatment Market Size Report 2034: Emerging Therap …
DelveInsight's "Cutaneous Lupus Erythematosus Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Cutaneous Lupus Erythematosus, historical and forecasted epidemiology…
Warts Treatment Market Size Report 2032: Emerging Therapies and Future Growth Op …
DelveInsight's "Warts Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Warts, historical and forecasted epidemiology as well as the Warts…
Sjogren's Syndrome Pipeline Appears Robust With 15+ Key Pharma Companies Activel …
DelveInsight's, "Sjogren's syndrome Pipeline Insight, 2025" report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Sjogren's syndrome pipeline landscape. It covers the…
MELAS Syndrome Pipeline Appears Robust With 4+ Key Pharma Companies Actively Wor …
DelveInsight's "MELAS Syndrome Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in MELAS Syndrome pipeline landscape. It covers the…
Autism Spectrum Disorder Pipeline Appears Robust With 18+ Key Pharma Companies A …
DelveInsight's, "Autism Spectrum Disorder Pipeline Insight, 2025" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Autism Spectrum Disorder pipeline landscape. It…
Familial Adenomatous Polyposis Pipeline Appears Robust With 4+ Key Pharma Compan …
"DelveInsight's, "Familial adenomatous polyposis Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Familial adenomatous polyposis pipeline landscape. It…
Cushing Syndrome Pipeline Appears Robust With 4+ Key Pharma Companies Actively W …
DelveInsight's, "Cushing Syndrome Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Cushing Syndrome pipeline landscape. It covers the…
Acute Graft-versus-Host Disease Pipeline 2025: Groundbreaking Clinical Advanceme …
With Acute Graft-versus-Host Disease reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Chemotherapy Induced Peripheral Neuropathy (CIPN) Pipeline 2025: Groundbreaking …
With Chemotherapy Induced Peripheral Neuropathy (CIPN) reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there…
Go To Page: 1 2 3 4 5 6 7 8 9 10 31 32 33 34 35 36 37 38 39 40
